Median survival measures (DFS, BPFS, ΔBPFS-DFS) were all longer for HER-2 score 0 CRC patients compared to those with HER-2 1+/2+/3+ tumors, but none of the comparisons reached statistical significance. Here, ERBB2 is linked to colorectal carcinoma.